Search

everythinglearnresearchcommunity

for

Search:↓

Postpartum hair loss usually stops within 4-6 months.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Female pattern hair loss is common and increases with age.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

FGF9 from certain cells can trigger new hair growth during wound healing, but humans have fewer of these cells, which may limit hair regrowth.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Baricitinib successfully treated severe hair loss.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

A substance called FGF9 from certain immune cells can trigger new hair growth during wound healing in mice, but humans may not have the same response due to fewer of these cells.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Hair transplants can rarely cause scalp inflammation leading to hair loss, needing early detection and treatment.

Two people lost a lot of hair because of epilepsy drugs, but their hair grew back after changing medication.

Infliximab may cause hair loss in Crohn's disease patients.

A woman developed a skin condition called Pemphigus Vulgaris after a treatment to help with hair loss.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

HAIR may cause fetal loss by triggering different cell death processes in the uterus and placenta.

COVID-19 may trigger hair loss conditions like alopecia areata.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.